We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $8.34B
1-Year Est. Return 165.53%
This Fund
S&P 500
This Quarter Est. Return
+77.9%
1 Year Est. Return
+165.53%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.34B
AUM Growth
+$2.35B
Cap. Flow
-$42M
Cap. Flow %
-0.5%
Top 10 Hldgs %
46.57%
Holding
644
New
20
Increased
132
Reduced
424
Closed
57

Top Buys

Rank Stock Value
1
INIO
INNIO N.V.
INIO
+$177M
2
AMD icon
Advanced Micro Devices
AMD
+$119M
3
FORM icon
FormFactor
FORM
+$101M
4
CBRS
Cerebras Systems
CBRS
+$70.1M
5
ONTO icon
Onto Innovation
ONTO
+$64.5M

Top Sells

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$220M
2
LITE icon
Lumentum
LITE
+$219M
3
TSLA icon
Tesla
TSLA
+$50.1M
4
CIEN icon
Ciena
CIEN
+$43.3M
5
MSFT icon
Microsoft
MSFT
+$42.6M

Sector Composition

Rank Sector Weight
1 Technology 66.11%
2 Communication Services 9.64%
3 Consumer Discretionary 8.42%
4 Industrials 4.35%
5 Healthcare 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRK icon
251
Comstock Resources
CRK
$4.48B
$269K ﹤0.01%
18,044
-7,864
-30% -$120K
AXSM icon
252
Axsome Therapeutics
AXSM
$10.8B
$266K ﹤0.01%
1,085
-48
-4% -$10.4K
MDGL icon
253
Madrigal Pharmaceuticals
MDGL
$12.5B
$262K ﹤0.01%
488
-22
-4% -$11.3K
ESS icon
254
Essex Property Trust
ESS
$17.9B
$255K ﹤0.01%
873
-101
-10% -$27.1K
GPRE icon
255
Green Plains
GPRE
$1.08B
$245K ﹤0.01%
15,935
-6,927
-30% -$110K
ARWR icon
256
Arrowhead Research
ARWR
$12.2B
$242K ﹤0.01%
2,965
-85
-3% -$6.28K
SMMT icon
257
Summit Therapeutics
SMMT
$14B
$239K ﹤0.01%
16,404
-316
-2% -$5.6K
BMRN icon
258
BioMarin Pharmaceuticals
BMRN
$12.9B
$233K ﹤0.01%
4,071
-244
-6% -$13.4K
HSIC icon
259
Henry Schein
HSIC
$10B
$233K ﹤0.01%
2,789
+29
+1% +$2.22K
BKV
260
BKV Corp
BKV
$2.85B
$232K ﹤0.01%
8,463
+93
+1% +$2.56K
UHS icon
261
Universal Health Services
UHS
$10B
$231K ﹤0.01%
1,555
+16
+1% +$2.6K
KRYS icon
262
Krystal Biotech
KRYS
$10.6B
$230K ﹤0.01%
620
-31
-5% -$9.26K
KIM icon
263
Kimco Realty
KIM
$15.8B
$227K ﹤0.01%
8,953
-1,282
-13% -$30.8K
BNTX icon
264
BioNTech
BNTX
$26.1B
$225K ﹤0.01%
2,414
+144
+6% +$13.6K
T icon
265
AT&T
T
$176B
$223K ﹤0.01%
10,768
– –
CYTK icon
266
Cytokinetics
CYTK
$10.1B
$222K ﹤0.01%
2,608
-138
-5% -$9.91K
SNY icon
267
Sanofi
SNY
$106B
$221K ﹤0.01%
5,180
-763
-13% -$34.1K
HST icon
268
Host Hotels & Resorts
HST
$15.1B
$220K ﹤0.01%
9,260
-1,131
-11% -$25.2K
INVH icon
269
Invitation Homes
INVH
$16.9B
$217K ﹤0.01%
7,195
-1,607
-18% -$45.5K
MAA icon
270
Mid-America Apartment Communities
MAA
$14.9B
$215K ﹤0.01%
1,551
-219
-12% -$28.6K
TEM
271
Tempus AI
TEM
$11.7B
$213K ﹤0.01%
3,677
-206
-5% -$10.3K
WPC icon
272
W.P. Carey
WPC
$16B
$212K ﹤0.01%
2,965
-346
-10% -$25.4K
DVA icon
273
DaVita
DVA
$11.7B
$199K ﹤0.01%
895
-185
-17% -$33.6K
KYMR icon
274
Kymera Therapeutics
KYMR
$9.76B
$198K ﹤0.01%
1,729
+113
+7% +$9.71K
PRAX icon
275
Praxis Precision Medicines
PRAX
$9.82B
$198K ﹤0.01%
592
+30
+5% +$9.5K
9 10
11
12 13

Similar funds

GLF
Groupe la Francaise Paris, France $8.31B AUM 37.53% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
MWM
Modern Wealth Management Lenexa, Kansas $8.4B AUM 21.02% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $8.41B AUM

GF Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, GF Fund Management held 644 positions worth $8.34B, up 39% from $5.98B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

GF Fund Management's Q2 2026 filing shows 20 new, 132 increased, 424 reduced and 57 closed positions. Its largest new stake was INNIO N.V.: 4,970,000 shares worth $197M. The largest sale was Tower Semiconductor, an estimated $220M.

By sector, the portfolio is most concentrated in Technology at 66% of assets, up from 54% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q2 2026 buy was INNIO N.V.: 4,970,000 shares worth $197M.
  • GF Fund Management added most to Advanced Micro Devices in Q2 2026, an estimated $119M increase.
  • GF Fund Management's biggest Q2 2026 reduction was Tower Semiconductor, cutting an estimated $220M.
  • GF Fund Management fully exited Coherent in Q2 2026, selling an estimated $23.3M.
  • GF Fund Management's ten largest holdings make up 47% of its $8.34B portfolio in Q2 2026.
  • GF Fund Management opened 20 new positions and closed 57 in Q2 2026.
  • GF Fund Management's portfolio value rose 39% quarter-over-quarter to $8.34B.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.